Tech Company Inital Public Offerings
Renovia IPO
Renovia was bought by . Renovia shares started trading on 9/25/2018.
Transaction Overview
Company Name
Announced On
9/25/2018
Transaction Type
Venture Equity
IPO
IPO
Amount
$42,300,000
Proceeds Purpose
Proceeds from the funding will be used to support Renovia's clinical trials, product development pipeline, corporate development, and future commercial launches.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
263 Summer St. 5th Floor
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Renovia was formed to better diagnose, treat, and potentially improve the lives of millions of women through a platform of innovative sensor technologies combined with a digital health platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eileen Maus
Chief Medical Officer
Samantha Pulliam
VP - General Counsel
James O'Connor
VP - Human Resources
Robin Sutherland
VP - Regulatory Affairs
Jessica McKinney
Browse more venture capital transactions:
Prev: 9/25/2018: Socotra venture capital transaction
Next: 9/26/2018: MAXEX venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs